With the recent change of administration, the FDA’s long-awaited enforcement guidance on cannabidiol (CBD) is now on hold...
The transition from President Donald Trump to President Joe Biden will result in significant policy changes, and the cannabis industry is already feeling the impact. The U.S. Food and Drug Administration’s (FDA) long-awaited enforcement guidance on cannabidiol (CBD) is now on hold. In addition, the U.S. Department of Agriculture’s (USDA’s) final hemp rules must now be reviewed by the Biden Administration before taking effect.
FDA CBD Enforcement Guidance
While the 2018 Farm Bill legalized hemp, it is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement. As discussed in greater detail in prior articles, the FDA is currently in the process of determining how to approach CBD regulation.
The FDA submitted its Cannabidiol Enforcement Policy Draft Guidance for Industry to the White House Office of Management and Budget (OMB) this summer, sparking hope that long-awaited industry guidance was on the horizon. However, the OMB pulled the FDA guidance from its review process in response to a memorandum issued by President Biden.
The memo, entitled “Regulatory Freeze Pending Review,” directs that proposed rules should not be sent to the Office of the Federal Register (OFR) until a department or agency head of the new administration reviews and approves the rule. With respect to rules that have been sent to the OFR but not published in the Federal Register, they must be immediately withdrawn from the OFR for review and approval.
It is unclear if the FDA will deviate from its methodical approach to CBD regulation under the Biden Administration. There is also no timeline for when the FDA may resubmit its proposed guidance. In a statement to Hemp Industry Daily, a spokesperson for the FDA said that the agency “will work closely with the new administration to advance appropriate regulations and policies that are in line with the agency’s public health mission.”
USDA Hemp Regulations
On January 15, 2020, the USDA published its much-anticipated Final Rule on Establishment of a Domestic Hemp Production Program. While the USDA’s hemp regulation is much further along in the rulemaking process than the FDA CBD guidance, its fate is also uncertain.
With respect to rules that have been published in the Federal Register, or rules that have been issued in any manner, but have not taken effect, the Biden Administration’s memo recommends that agencies consider postponing the rules’ effective dates for 60 days from the date of the memorandum for the “purpose of reviewing any questions of fact, law, and policy the rules may raise.” The memo also recommends that agencies consider opening a 30-day comment period during the 60-day postponement period, and consider pending petitions for reconsideration involving such rules.
The good news is that the USDA’s Final Rule has not been officially withdrawn or placed on hold. A USDA spokesperson told Hemp Industry Daily that “we have no specific programs or rules to point to at this time that are on hold, but it’s proper for a new administration to have adequate time to review existing programs as well as those implemented by the previous administration in the final days of their tenure.” Another positive development is that the Biden Administration’s pick for Agriculture Secretary, Tom Vilsack, is considered to be a friend of the hemp industry.
Key Takeaway
While there was hope that 2021 would bring greater legal certainty to the hemp industry, it appears we may need to wait a little longer. In the absence of clear regulations, it is imperative to stay up-to-date on the latest legal developments and to consult with an experienced cannabis attorney who understands how to navigate the complex and rapidly evolving regulatory landscape.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Top 5 Causes Leading to Construction Defect Litigation
The five most common causes of construction defect litigation are design defects, substandard materials, workmanship defects, code violations, and subsurface defects. Because these flaws can compromise a building’s integrity, functionality, or safety, they frequently lead to disputes involving multiple parties and high financial stakes. Key takeaways: What is Construction Defect Litigation? Construction litigation is complex, […]
How to Protect Your New Jersey Business When Going through a Divorce
The most effective ways to protect your business in a divorce are put in place before one begins: a prenuptial or postnuptial agreement, clean separation of business and personal finances, and divorce contingencies built into your operating or buy-sell agreements. If divorce is already underway, the priorities shift to establishing how the business is classified […]
The most common franchise disputes involve breach of contract, franchise termination and non-renewal, intellectual property rights, territorial encroachment, royalty and fee payments, franchisor support obligations, and violations of state franchise laws such as the New Jersey Franchise Practices Act. Franchisors and franchisees can often resolve these conflicts by providing written notice detailing the dispute and […]
Reputational Risk and Legal Exposure: Why New Jersey Businesses Must Manage Them Together
New Jersey businesses must manage legal and reputational risk together because modern disputes play out on two fronts at once: the legal proceeding itself and the court of public opinion, where customers, employees, investors, and business partners often reach conclusions long before a judge or jury has had the opportunity to evaluate the facts. Success […]
Eviction Is Not Always the End: Understanding Post-Possession Rent Claims in New Jersey and New York
No. An eviction does not automatically end a tenant’s obligation to pay rent. Post-eviction rent claims are common because recovering possession resolves who has the right to occupy the premises, but it does not extinguish the tenant’s contractual obligations under the lease. Whether unpaid or future rent remains owed depends on three factors: the lease’s […]
Company Dissolved? Legal and Financial Consequences to Expect
A company is dissolved; legally, it ceases to exist. Accordingly, dissolution results in significant legal and financial consequences. It is a process that must be properly managed to avoid continuing liability. The Corporate Dissolution Process Corporate dissolution is the legal process of formally closing a corporation, paying its debts and distributing the remaining assets. Most […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
